Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cymbalta in fibromyalgia
NCT01552057Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2012
- Primary completion
- Dec 2013
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in fibromyalgia (FM) comparing Duloxetine 60 mg with Placebo (2 arms). Primary endpoint: Brief Pain Inventory 24-Hour Average Pain Severity at 14 weeks. Started Mar 2012; status: completed.
02
Drugs
duloxetine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01552057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01552057.